Pathologic Function: Depressions, Ventilatory

Medical news and research articles

FDA approves nasal spray for treatment-resistant depression

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral antidepressants, according ...

New analgesic could replace opioids over the long term

Opioids have long been known as natural substances with substantial pharmacological effects and have been used as effective painkillers. A very prominent example is morphine, which was first isolated and synthesized in the ...

page 1 from 2